✕
Zydus Cadila has received the final approval from USFDA to market 20 mg (base) and 40 mg (base) Eletriptan Hydrobromide tablets which are used in the treatment of migraine...
http://bit.ly/2sNB9qc
http://bit.ly/2sNB9qc
Dr. T●●●j S●●●●●i and 6 others like this
Like
Comment
Share